Tapewire

Nasdaq · USD

ASND

Ascendis Pharma A/S

Export transactions ↓
Tapewire entity
1628
SEC CIK
0001612042
Parsed reports
25

Last 12 months

Inside the activity.

9 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202661
Jun 202610
Jul 202600
Aug 202620
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2026 Filed Sep 9, 2026 21:04 UTC Exercise / conversionWarrants · Derivative 3,000 $0.00 Strike: $110.00 $0.00
Disclosure

SEC source: 0001610717-26-000409 · form4.xml · derivative · entry 3

Bodenhoff Mads · CIK 0002014697 · SVP & PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 687

Underlying: Ordinary Shares · 3,000 shares

Expires 2032-10-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The warrants vested 25% on October 11, 2023 and thereafter in 36 equal monthly installments.

Read SEC document
September 08, 2026 Filed Sep 9, 2026 21:04 UTC SaleOrdinary Shares 3,000 $270.19 $810,570.00
Disclosure

SEC source: 0001610717-26-000409 · form4.xml · nonDerivative · entry 2

Bodenhoff Mads · CIK 0002014697 · SVP & PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 08, 2026 Filed Sep 9, 2026 21:04 UTC Exercise / conversionOrdinary Shares 3,000 $110.00 $330,000.00
Disclosure

SEC source: 0001610717-26-000409 · form4.xml · nonDerivative · entry 1

Bodenhoff Mads · CIK 0002014697 · SVP & PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:09 UTC
HOLTUG LARSDirector
SaleOrdinary Shares 236 $264.13 $62,334.59
Disclosure

SEC source: 0001610717-26-000395 · form4.xml · nonDerivative · entry 1

HOLTUG LARS · CIK 0001965626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
August 14, 2026 Filed Aug 19, 2026 01:02 UTC PurchaseOrdinary Shares 900 $246.91 $222,219.00
Disclosure

SEC source: 0001610717-26-000360 · form4.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,900

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 14, 2026 Filed Aug 19, 2026 01:02 UTC PurchaseOrdinary Shares 1,100 $245.85 $270,435.00
Disclosure

SEC source: 0001610717-26-000360 · form4.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
June 02, 2026 Filed Jun 2, 2026 20:25 UTC
SMITH SCOTT THOMASEVP & Chief Financial Officer
PurchaseOrdinary Shares 100 $219.00 $21,900.00
Disclosure

SEC source: 0001610717-26-000179 · form4.xml · nonDerivative · entry 1

SMITH SCOTT THOMAS · CIK 0001965550 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,367

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:10 UTC
SMITH SCOTT THOMASEVP & Chief Financial Officer
PurchaseOrdinary Shares 250 $223.32 $55,830.00
Disclosure

SEC source: 0001610717-26-000176 · form4.xml · nonDerivative · entry 1

SMITH SCOTT THOMAS · CIK 0001965550 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,267

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:11 UTC PurchaseOrdinary Shares 100 $223.50 $22,350.00
Disclosure

SEC source: 0001610717-26-000177 · form4.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:11 UTC PurchaseOrdinary Shares 200 $222.30 $44,460.00
Disclosure

SEC source: 0001610717-26-000177 · form4.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:11 UTC PurchaseOrdinary Shares 200 $223.76 $44,752.00
Disclosure

SEC source: 0001610717-26-000177 · form4.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600

Read SEC document
May 26, 2026 Filed May 27, 2026 20:05 UTC PurchaseOrdinary Shares 200 $239.37 $47,873.50
Disclosure

SEC source: 0001610717-26-000161 · form4.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $239.245 to $239.490 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
May 26, 2026 Filed May 27, 2026 20:05 UTC PurchaseOrdinary Shares 200 $236.24 $47,247.00
Disclosure

SEC source: 0001610717-26-000161 · form4.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $235.93 to $236.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 20:08 UTC SaleOrdinary Shares 19,460 $238.49 $4,641,021.24
Disclosure

SEC source: 0001610717-26-000159 · form4.xml · nonDerivative · entry 1

JENSEN FLEMMING STEEN · CIK 0001965612 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
April 14, 2026 Filed Sep 28, 2026 20:08 UTC GrantWarrants · Derivative 9,160 Not disclosed Strike: $249.84 Not disclosed
Disclosure

SEC source: 0001610717-26-000423 · form4.xml · derivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,160

Underlying: Ordinary Shares · 9,160 shares

Expires 2036-04-14

F2 · price: The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer.

F3 · derivative.exercise_date: The warrants vest 25% on April 14, 2027 and thereafter in 36 equal monthly installments.

Read SEC document
April 14, 2026 Filed Sep 28, 2026 20:08 UTC Disposition to issuerWarrants · Derivative 9,160 Not disclosed Strike: $172.35 Not disclosed
Disclosure

SEC source: 0001610717-26-000423 · form4.xml · derivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 9,160 shares

Expires 2035-06-10

F2 · price: The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer.

F1 · derivative.exercise_date: The warrants vest 25% on June 10, 2026 and thereafter in 36 equal monthly installments.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.